Influencing Factors for the Acceptability of Accessing HIV Pre-exposure Prophylaxis via Community Pharmacies in Wales

被引:0
|
作者
Gillespie, David [1 ]
Williams, Adam D. N. [1 ]
Ma, Richard [2 ]
Couzens, Zoe [3 ]
Hood, Kerenza [1 ]
Hughes, Dyfrig A. [4 ]
Mantzourani, Efi [5 ]
Cochrane, Eleanor [6 ]
Wood, Fiona [7 ,8 ]
机构
[1] Cardiff Univ, Coll Biomed & Life Sci, Ctr Trials Res, Sch Med, Cardiff, Wales
[2] Univ Bristol, Ctr Acad Primary Care, Bristol Med Sch, Bristol, England
[3] Publ Hlth Wales NHS Trust, Cardiff, Wales
[4] Bangor Univ, Ctr Hlth Econ & Med Evaluat, Bangor, Wales
[5] Cardiff Univ, Coll Biomed & Life Sci, Sch Pharm, Cardiff, Wales
[6] Hlth Educ & Improvement Wales, Cardiff, Wales
[7] Cardiff Univ, Coll Biomed & Life Sci, Sch Med, Div Populat Med, Cardiff, Wales
[8] Cardiff Univ, Coll Biomed & Life Sci, PRIME Ctr Wales, Sch Med, Cardiff, Wales
关键词
community pharmacy; healthcare access; HIV; pre-exposure prophylaxis; primary care; qualitative research;
D O I
10.1111/hex.70247
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Introduction: HIV prevention methods, such as pre-exposure prophylaxis (PrEP), have been a significant contributing factor to a global decline in HIV transmission. PrEP has been available through the NHS in Wales since 2017. However, access is exclusively via sexual health clinics, and those accessing PrEP do not reflect those being diagnosed with HIV. Widening access beyond sexual health clinics may be one approach to encourage more equitable uptake, and there is growing interest in offering PrEP services in community pharmacies. We, therefore, aimed to explore the acceptability of PrEP services being delivered through community pharmacies among prospective service users. Methods: We conducted a qualitative interview study of people living in Wales who either (i) currently access, (ii) previously accessed or are (iii) considering accessing PrEP via a sexual health clinic. Participants were recruited via community networks, and interviews were conducted virtually. Our topic guide was informed by Levesque's conceptual framework of access to healthcare, and we used reflexive thematic analysis. Results: We interviewed 24 participants and included data from 20 in the analysis. Four themes were generated: experiences of accessing PrEP via sexual health clinics, the prospect of PrEP access via community pharmacies, other community settings in which PrEP may be accessed and concerns around integrated healthcare and healthcare data. Conclusion: PrEP access via community pharmacy is likely to be an acceptable option for people. There are uncertainties surrounding what a PrEP service would look like in a community pharmacy setting, and this would need clarifying to prospective users to increase the salience of access. Patient and Public Contribution: A team-based approach was taken for developing the topic guide and agreeing on the codes for this study. This included people with lived experience of accessing PrEP in Wales.
引用
收藏
页数:19
相关论文
共 50 条
  • [41] Preparing for pre-exposure prophylaxis: perceptions and readiness of Canadian pharmacists for the implementation of HIV pre-exposure prophylaxis
    Yoong, Deborah
    Naccarato, Mark
    Sharma, Malika
    Wilton, James
    Senn, Heather
    Tan, Darrell H. S.
    INTERNATIONAL JOURNAL OF STD & AIDS, 2016, 27 (08) : 608 - 616
  • [42] Assessment of Acceptability of Pre-exposure Prophylaxis for HIV Prevention Among Men Who Sex with Men and Transgender Community in Pakistan
    Ali, Usman
    Pasha, Safdar Kamal
    Patel, Rupa
    Schmidt, Heather-Marie
    Altaf, Arshad
    JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2023, 33 (09): : 983 - 989
  • [43] HIV pre-exposure prophylaxis: assessment of acceptability among members of HIV serodiscordant/serostatus unknown couples
    Bracho-Sanchez, Edith
    Stonbraker, Samantha
    Halpern, Mina
    Wood, Sarah
    Lowenthal, Elizabeth
    INTERNATIONAL JOURNAL OF STD & AIDS, 2022, 33 (07) : 687 - 693
  • [44] Knowledge, Attitudes, and Acceptability of Pre-Exposure Prophylaxis among Individuals Living with HIV in an Urban HIV Clinic
    Jayakumaran, Jenani Sarah
    Aaron, Erika
    Gracely, Ed J.
    Schriver, Emily
    Szep, Zsofia
    PLOS ONE, 2016, 11 (02):
  • [45] Pharmacists as providers of HIV pre-exposure prophylaxis
    Christine Bruno
    Parya Saberi
    International Journal of Clinical Pharmacy, 2012, 34 : 803 - 806
  • [46] Pre-exposure prophylaxis as HIV prevention in the UK
    Brady, Michael
    THERAPEUTIC ADVANCES IN CHRONIC DISEASE, 2016, 7 (03) : 150 - 152
  • [47] HIV moments and pre-exposure prophylaxis Reply
    Dunn, David T.
    Gafos, Mitzy
    White, Ellen
    McCormack, Sheena
    LANCET, 2016, 387 (10027): : 1508 - 1508
  • [48] Why Do HIV Pre-Exposure Prophylaxis Users Discontinue Pre-Exposure Prophylaxis Care? A Mixed Methods Survey in a Pre-Exposure Prophylaxis Clinic in Belgium
    Vanbaelen, Thibaut
    Rotsaert, Anke
    Jacobs, Bart K. M.
    Florence, Eric
    Kenyon, Chris
    Vuylsteke, Bea
    Laga, Marie
    Thijs, Reyniers
    AIDS PATIENT CARE AND STDS, 2022, 36 (04) : 159 - 167
  • [49] HIV pre-exposure prophylaxis: effective and underused
    Hempel, Amanda
    Biondi, Mia J.
    Baril, Jean-Guy
    Tan, Darrell H. S.
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2022, 194 (45) : E1544 - E1550
  • [50] Pharmacists as providers of HIV pre-exposure prophylaxis
    Bruno, Christine
    Saberi, Parya
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2012, 34 (06) : 803 - 806